Exploring the effects of TRPV1 channel activation in the locus coeruleus on morphine-induced analgesia in rats with diabetic neuropathy using the hot-plate test

Document Type : Original Research

Authors
1 Department of Biology, Faculty of Basic Sciences, Islamic Azad University of Hamadan, Iran
2 Neurophysiology Research Center, Hamadan University of Medical Sciences, Hamadan, Iran
3 Department of Neuroscience, School of Sciences and Advanced Technology in Medicine, Hamadan University of Medical Sciences, Hamadan, Iran
Abstract
Introduction: Diabetic neuropathies (DN), a group of neuropathic disorders linked to diabetes mellitus, often manifest as peripheral neuropathy characterized by hyperalgesia and can affect all forms of diabetes. Morphine is known to inhibit the activity of locus coeruleus (LC) neurons, which play a crucial role in pain modulation. The TRPV1 receptor, associated with capsaicin, is expressed in several brain nuclei involved in pain perception, including the LC nucleus. This study aims to investigate the influence of TRPV1 in the LC on thermal hyperalgesia in both morphine-dependent and non-dependent rats suffering from DN.

Methods: This study involved male Wistar rats, with diabetic neuropathy (DN) induced by administering streptozotocin (STZ) at a dose of 60 mg/kg. Morphine sulfate, at a dosage of 3 mg/kg, was administered intraperitoneally once daily for three consecutive days. Subsequently, we explored the activation of TRPV1 channels using capsaicin, at a concentration of 10 nmol, in mediating thermal hyperalgesia in both normal and neuropathic rats.

Results: Our findings revealed that activation of TRPV1 receptors in the LC significantly restored the decreased hot plate threshold in diabetic non-dependent rats. Conversely, this activation had no impact on diabetic-morphine-dependent rats.

Conclusion: The findings of this study imply that targeting the capsaicinoid system may serve as an effective pharmacological strategy for treating patients with peripheral neuropathy.

Keywords

Subjects


[1] Strand N, Anderson MA, Attanti S, Gill B, Wie C, Dawodu A, et al. Diabetic Neuropathy: Pathophysiology Review. Current pain and headache reports. 2024;28(6):481-7.
[2] Poe GR, Foote S, Eschenko O, Johansen JP, Bouret S, Aston-Jones G, et al. Locus coeruleus: a new look at the blue spot. Nature Reviews Neuroscience. 2020;21(11):644-59.
[3] Amaral DG, Sinnamon HM. The locus coeruleus: neurobiology of a central noradrenergic nucleus. Progress in neurobiology. 1977;9(3):147-96.
[4] Aston-Jones G, Zhu Y, Card JP. Numerous GABAergic afferents to locus ceruleus in the pericerulear dendritic zone: possible interneuronal pool. Journal of Neuroscience. 2004;24(9):2313-21.
[5] Shipley MT, Fu L, Ennis M, Liu WL, Aston‐Jones G. Dendrites of locus coeruleus neurons extend preferentially into two pericoerulear zones. Journal of Comparative Neurology. 1996;365(1):56-68.
[6] España JC, Yasoda-Mohan A, Vanneste S. The Locus Coeruleus in Chronic Pain. International Journal of Molecular Sciences. 2024;25(16):8636.
[7] Chapa-Oliver AM, Mejía-Teniente L. Capsaicin: From plants to a cancer-suppressing agent. Molecules. 2016;21(8):931.
[8] Wang L, Wang DH. TRPV1 gene knockout impairs postischemic recovery in isolated perfused heart in mice. Circulation. 2005;112(23):3617-23.
[9] Cortright DN, Szallasi A. Biochemical pharmacology of the vanilloid receptor TRPV1: an update. European journal of biochemistry. 2004;271(10):1814-9.
[10] Samanta A, Hughes TE, Moiseenkova-Bell VY. Transient receptor potential (TRP) channels. Membrane protein complexes: Structure and function. 2018:141-65.
[11] Arora V, Campbell JN, Chung M-K. Fight fire with fire: Neurobiology of capsaicin-induced analgesia for chronic pain. Pharmacology & therapeutics. 2021;220:107743.
[12] Wang Y, Kedei N, Wang M, Wang QJ, Huppler AR, Toth A, et al. Interaction between protein kinase Cμ and the vanilloid receptor type 1. Journal of biological chemistry. 2004;279(51):53674-82.
[13] Starowicz K, Maione S, Cristino L, Palazzo E, Marabese I, Rossi F, et al. Tonic endovanilloid facilitation of glutamate release in brainstem descending antinociceptive pathways. Journal of Neuroscience. 2007;27(50):13739-49.
[14] Listos J, Łupina M, Talarek S, Mazur A, Orzelska-Górka J, Kotlińska J. The mechanisms involved in morphine addiction: an overview. International journal of molecular sciences. 2019;20(17):4302.
[15] Feldman EL, Callaghan BC, Pop-Busui R, Zochodne DW, Wright DE, Bennett DL, et al. Diabetic neuropathy. Nature reviews Disease primers. 2019;5(1):1-18.
[16] Sharma S, Kulkarni SK, Chopra K. Effect of resveratrol, a polyphenolic phytoalexin, on thermal hyperalgesia in a mouse model of diabetic neuropathic pain. Fundamental & clinical pharmacology. 2007;21(1):89-94.
[17] Chung M-K, Campbell JN. Use of capsaicin to treat pain: mechanistic and therapeutic considerations. Pharmaceuticals. 2016;9(4):66.
[18] Liao HT, Lee HJ, Ho YC, Chiou LC. Capsaicin in the periaqueductal gray induces analgesia via metabotropic glutamate receptor‐mediated endocannabinoid retrograde disinhibition. British journal of pharmacology. 2011;163(2):330-45.
[19] Vertes RP. Interactions among the medial prefrontal cortex, hippocampus and midline thalamus in emotional and cognitive processing in the rat. Neuroscience. 2006;142(1):1-20.